Detalhe da pesquisa
1.
Ibrexafungerp Demonstrates In Vitro Activity against Fluconazole-Resistant Candida auris and In Vivo Efficacy with Delayed Initiation of Therapy in an Experimental Model of Invasive Candidiasis.
Antimicrob Agents Chemother
; 65(6)2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33753333
2.
The Novel Arylamidine T-2307 Demonstrates In Vitro and In Vivo Activity against Candida auris.
Antimicrob Agents Chemother
; 64(3)2020 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31844006
3.
Extended-Interval Dosing of Rezafungin against Azole-Resistant Aspergillus fumigatus.
Antimicrob Agents Chemother
; 63(10)2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31405851
4.
Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis.
Antimicrob Agents Chemother
; 63(11)2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31427304
5.
The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates In Vitro and In Vivo Activity against Candida auris.
Antimicrob Agents Chemother
; 63(3)2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30530603
6.
The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis.
Antimicrob Agents Chemother
; 62(9)2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29941638
7.
The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitis.
Antimicrob Agents Chemother
; 62(4)2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29437615
8.
The Fungal Cyp51 Inhibitor VT-1129 Is Efficacious in an Experimental Model of Cryptococcal Meningitis.
Antimicrob Agents Chemother
; 62(9)2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29987152
9.
In Vivo Efficacy of VT-1129 against Experimental Cryptococcal Meningitis with the Use of a Loading Dose-Maintenance Dose Administration Strategy.
Antimicrob Agents Chemother
; 62(11)2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30104280
10.
Oral glucan synthase inhibitor SCY-078 is effective in an experimental murine model of invasive candidiasis caused by WT and echinocandin-resistant Candida glabrata.
J Antimicrob Chemother
; 73(2): 448-451, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29177447
11.
Isavuconazole Is Effective for the Treatment of Experimental Cryptococcal Meningitis.
Antimicrob Agents Chemother
; 60(9): 5600-3, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27324761
12.
Effect of Antifungal Treatment in a Diet-Based Murine Model of Disseminated Candidiasis Acquired via the Gastrointestinal Tract.
Antimicrob Agents Chemother
; 60(11): 6703-6708, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27572393
13.
The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against echinocandin-resistant Candida glabrata.
J Antimicrob Chemother
; 71(3): 692-5, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26620102
14.
The novel arylamidine T-2307 maintains in vitro and in vivo activity against echinocandin-resistant Candida albicans.
Antimicrob Agents Chemother
; 59(2): 1341-3, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25451054
15.
The investigational agent E1210 is effective in treatment of experimental invasive candidiasis caused by resistant Candida albicans.
Antimicrob Agents Chemother
; 59(1): 690-2, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25331706
16.
Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis.
Antimicrob Agents Chemother
; 52(3): 1176-8, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18160526
17.
In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera.
Antimicrob Agents Chemother
; 51(5): 1616-20, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17307976